Aim: to identify the degree of cognitive impairment (CN) and to optimize the treatment of patients with multiple sclerosis (MS). Material and methods. A total of 695 patients (278 men and 417 women) were ranged from 18 to 63 years. The mean age was 30.2±0.7 years: women (417) 28.5±0.5 years, while for men (278) 31.8±0.7 years. Relaps-ing-remitting type (RT) of MS was established in 520 patients (74.8%), secondary progressive type (VPT MS) in 132 patients (18.9%) and primary progressive type (PPT MS) in 10 patients (1.5%). Clinically isolated syndrome (CIS) was detected in 33 patients (4.8%). The diagnosis of MS 662 patients according to the criteria McDonald etal. (2005). Score of neurologic deficit was carried out on an extended scale of d...
Objectives: To investigate the presence and the nature of cognitive impairment in a large sample of ...
Objectives: To investigate the presence and the nature of cognitive impairment in a large sample of ...
Cognitive decline is recognized as a prevalent and debilitating symptom of multiple sclerosis (MS), ...
Cognitive impairment (CI) has a prevalence of 45-70% in people with multiple sclerosis (MS), produci...
Cognitive impairment can emerge in the earliest phases of multiple sclerosis. It strongly impacts di...
Abstract Background About 40–70% of patients with multiple sclerosis (MS) develop cognitive impairme...
The purpose of this study is to evaluate the cognitive functions in cases with relapsing remitting M...
THESIS 10333Cognitive impairment (CI) affects up to 65% of multiple sclerosis (MS) patients and can ...
Cognitive impairment (CI) is a common symptom of multiple sclerosis (MS), with a significant negativ...
The purpose of this study is to evaluate the cognitive functions in cases with relapsing remitting M...
Neuropsychological assessment of cognitive functions in multiple sclerosis (MS) is increasingly cons...
The purpose of the study was to identify changes in cognitive abilities that affect patients with re...
Multiple sclerosis; Neurophysiological monitoring; Neuropsychological testsEsclerosi múltiple; Monit...
There is limited and inconsistent information on the clinical determinants of cognitive impairment (...
Multiple sclerosis is a chronic, demyelinating disease of the CNS. Cognitive impairment is a sometim...
Objectives: To investigate the presence and the nature of cognitive impairment in a large sample of ...
Objectives: To investigate the presence and the nature of cognitive impairment in a large sample of ...
Cognitive decline is recognized as a prevalent and debilitating symptom of multiple sclerosis (MS), ...
Cognitive impairment (CI) has a prevalence of 45-70% in people with multiple sclerosis (MS), produci...
Cognitive impairment can emerge in the earliest phases of multiple sclerosis. It strongly impacts di...
Abstract Background About 40–70% of patients with multiple sclerosis (MS) develop cognitive impairme...
The purpose of this study is to evaluate the cognitive functions in cases with relapsing remitting M...
THESIS 10333Cognitive impairment (CI) affects up to 65% of multiple sclerosis (MS) patients and can ...
Cognitive impairment (CI) is a common symptom of multiple sclerosis (MS), with a significant negativ...
The purpose of this study is to evaluate the cognitive functions in cases with relapsing remitting M...
Neuropsychological assessment of cognitive functions in multiple sclerosis (MS) is increasingly cons...
The purpose of the study was to identify changes in cognitive abilities that affect patients with re...
Multiple sclerosis; Neurophysiological monitoring; Neuropsychological testsEsclerosi múltiple; Monit...
There is limited and inconsistent information on the clinical determinants of cognitive impairment (...
Multiple sclerosis is a chronic, demyelinating disease of the CNS. Cognitive impairment is a sometim...
Objectives: To investigate the presence and the nature of cognitive impairment in a large sample of ...
Objectives: To investigate the presence and the nature of cognitive impairment in a large sample of ...
Cognitive decline is recognized as a prevalent and debilitating symptom of multiple sclerosis (MS), ...